News tagged with drug candidate
Alzheimer's drug candidate may be first to prevent disease progression
A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer's disease, based on the findings of a study published today in PLoS One.
Medicine & Health / Medications
Dec 14, 2011 |
4.8 / 5 (17) |
0
|
Breakthrough could speed drug discovery
(Medical Xpress) -- Innovative technology being pioneered at Cardiff to speed up the discovery of new drugs to tackle lung diseases could also dramatically reduce testing on animals.
Nov 25, 2011 |
5 / 5 (3) |
0
Scientists develop new class of small molecules through innovative chemistry
Inspired by natural products, scientists on the Florida campus of the Scripps Research Institute have created a new class of small molecules with the potential to serve as a rich foundation for drug discovery.
Nov 20, 2011 |
5 / 5 (2) |
1
|
MU scientist eyeing enzymes that could help fight flu
The influenza virus remains a worldwide threat to humans, causing an average of 36,000 deaths and 200,000 hospitalizations each year in the United States alone. As health care professionals prepare for another ...
Nov 17, 2011 |
not rated yet |
0
Scientists discover new drug candidates for cystic fibrosis and other diseases
A new discovery by Californian scientists may lead to a pharmaceutical breakthrough for a wide range of illnesses that involve the hydration of cells that line the inner surfaces of our body's organs and tissues. In a new ...
Medicine & Health / Medications
Nov 01, 2011 |
not rated yet |
0
Rapid profiling of drug candidates
In the hunt for new medicines, any technique that expedites drug candidates into the clinic is a welcome advance. A team led by Hiroyuki Osada at the RIKEN Advanced Science Institute, Wako, recently developed ...
Chemistry / Analytical Chemistry
Sep 22, 2011 |
not rated yet |
0
Hope for powerful new C diff. treatment
MGB Biopharma, a biopharmaceutical company which has licensed technology from the University of Strathclyde in Glasgow, Scotland, is developing a powerful new antibiotic treatment for resistant infections including the deadly ...
Sep 19, 2011 |
not rated yet |
0
Treatment provides dramatic survival benefit for hard-to-match kidney transplant patients
Hard-to-match kidney transplant candidates who receive a treatment designed to make their bodies more accepting of incompatible organs are twice as likely to survive eight years after transplant surgery as those who stay ...
Jul 27, 2011 |
not rated yet |
0
Scientists discover drug candidate for Alzheimer's, Huntington's disease
Scientists at the Gladstone Institutes have identified a drug candidate that diminishes the effects of both Alzheimer's disease and Huntington's disease in animal models, offering new hope for patients who currently lack ...
Jun 02, 2011 |
not rated yet |
0
Pfizer says patient died in oral RA drug study
(AP) -- Pfizer Inc. confirmed that one patient who was taking its drug candidate tofacitinib, a pill designed to treat rheumatoid arthritis, died during a recent clinical trial and said the death was connected to the drug.
Medicine & Health / Medications
Apr 22, 2011 |
not rated yet |
0
HIV-infected organs can save lives, doctors say
The nation has a huge need for kidneys, livers and other organs for transplant, but federal law has one absolute rule for donors: no HIV infections.
Apr 12, 2011 |
not rated yet |
0
Scientists discover a way to kill off tumors in cancer treatment breakthrough
Scientists from the School of Pharmacy at Queen's University Belfast and Almac Discovery Ltd have developed a new treatment for cancer which rather than attacking tumours directly, prevents the growth of new blood vessels ...
Apr 05, 2011 |
4.8 / 5 (13) |
7
|
Intelligent design: Engineered protein fragment blocks the AIDS virus from entering cells
In what could be a potential breakthrough in the battle against AIDS and a major development in the rational design of new drugs, scientists have engineered a new protein that prevents the virus from entering cells. This ...
Mar 31, 2011 |
5 / 5 (1) |
2
Cytokinetics announces fundamental research in cardiac myosin activation
Cytokinetics, Inc. announced today the publication of preclinical research in the March 18, 2011 issue of the journal Science regarding the activation of cardiac myosin by an investigational drug candidate, omecamtiv mecarb ...
Mar 17, 2011 |
not rated yet |
0
Modeling retinitis pigmentosa with iPS cells
Retinitis pigmentosa (RP) is a cluster of genetically determined eye disorders that cause visual defects such as night blindness and narrowing of the field of vision, due to progressive loss of rod photoreceptors. ...
Mar 09, 2011 |
not rated yet |
0
